MDCX · Medicus Pharma Ltd. · Executive Compensation
$1.89
+0.02 (+0.96%)
At close · Nov 9
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“This uncertainty, together with the Company's history of losses and its outstanding debt obligations, including debt that will become current by year-end 2026, indicates that substantial doubt exists about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed Nov 6, 2026
Market Cap
$3.60M
Shares
1.92M
Volume · Nov 9
61.9K
Avg daily vol (21 sessions)
75.51K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Carolyn Bonner | Chief Financial Officer | Appointed | 2025-12-01 |
| James Quinlan | Chief Financial Officer | Resigned | 2025-12-01 |
| Carolyn Bonner | acting Chief Financial Officer | Appointed | 2025-09-12 |
| Viktoria Slepeniuk | Member of Antev's Board of Directors | Appointed | 2025-09-02 |
| Carolyn Bonner | Member of Antev's Board of Directors | Appointed | 2025-09-02 |
| Faisal Mehmud | Co-Chairman of Antev's Board of Directors | Appointed | 2025-09-02 |
| Paul Marchetto | Co-Chairman of Antev's Board of Directors | Appointed | 2025-09-02 |
| Patrick J. Mahaffy | Member of Medicus's Board of Directors | Appointed | 2025-09-02 |
| Patrick J. Mahaffy | director | Appointed | 2025-09-02 |
| Andrew Smith | Chief Operating Officer | Appointed | 2025-06-23 |
Leadership
- Dr. Raza Bokhari CEO
- Faisal Mehmud Chairman
- Paul Marchetto Chairman
- Carolyn Bonner CFO, Board Member
- Andrew Smith COO
- Barry Fishman Board Member
- Patrick J. Mahaffy Board Member
- Viktoria Slepeniuk Board Member
- William L. Ashton Board Member
Key facts
CIK
1997296
CUSIP
58471K202
13F (30d)
10 filings
10 filers
Visit website
Investor relations